内镜下治疗后早期口服营养液对肝硬化食管胃底静脉曲张破裂再出血的预防作用*

doi:10.3969/j.issn.1672-5069.2016.04.030

Abstract

Jiang Hongmei, Liu Jianguang, Yang Jing. Early oral administration of Ensure in patients with liver cirrhosis complicated by esophageal -gastric varices after endoscopic hemostasis[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(4): 490-491.

References

[1] Graham DY，Smith JL. The course of patients after variceal hemorrhage. Gastroenterology，1981，80:800-809.
[2] 吴利敏，吴金明，刘扬，等. 肝硬化食管静脉曲张破裂出血早期再出血的危险因素分析. 实用医学杂志，2009，11（22）:3803-3805.
[3] 邹玉，肖玉良，张颖慧，等. 肝硬化食管胃静脉出血内镜治疗后早期口服营养液支持治疗疗效观察. 肝脏，2013，12（2）:134-135.
[4] 刘勤富. 肝硬化食管胃静脉曲张早期再出血危险因素分析.宁夏医科大学，2014.24（3）：38.
[5] 杨艳. 食管胃静脉曲张内镜治疗后早期再出血影响因素分析.北京中医药大学，2012.15（9）：45
[6] 李霄艳，邵海燕，杨光. 探讨饮食护理干预对肝硬化再出血发生率的影响. 中国卫生标准管理，2015，26（2）:197-198.
[7] 张鸿，严冬梅，范合璋. 内镜下曲张静脉套扎治疗食管静脉重度曲张患者60例. 实用肝脏病杂志，2013，16（4）：330-331
[8] 马超. 内镜下治疗食管胃底静脉曲张出血的疗效分析.安徽医科大学学报，2014.33（1）：55.
[9] 邹玉，刘晶华，张颖慧. 早期肠内营养在预防肝硬化食管静脉再出血中的价值探讨. 昆明医科大学学报，2013，13（1）:73-75.
[10] 陈颖君，范英华，乔羽. 精准肝切除病人围术期口服肠内营养制剂对术后康复的影响. 护理研究，2012，16（6）:1489-1490.
[11] 李来. 不同营养支持对肝硬化门静脉高压大鼠肠粘膜屏障功能的影响. 青岛大学，2004，15（1）：66.
[12] 张珍，王瑞兰，白志芳，等. 120例肝硬化肝癌切除术患者围手术期营养支持的护理体会. 北京医学，2014，11:970-972.
[13] 徐丽婷，杜慧，孙爱军，等.临床药师对1例丙肝肝硬化患者脾切除术后腹腔感染的药学监护. 中国药房，2014，18:1719-1723.
[14] 盛博，陈炜，赵磊. 肠内营养在肝癌合并肝炎后肝硬化患者围手术期的应用. 世界华人消化杂志，2013，28:2999-3003.

[1]	Zhuang Ying, Lin Zhihui.. Clinical manifestations and diagnosis of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 765-767.
[2]	Yang Caiyong, Chen Na, Li Kui, et al.. Clinical significance of peripheral blood Treg and Th17 cells in patients with chronic hepatitis C and hepatitis C-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 868-871.
[3]	Wu Dan Ma Xiangying.. Insulin resistance,carotid atherosclerosis and left ventricular function in patients with NAFLD-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 876-879.
[4]	He Zhi’an, Yu Liping, Lai Jiangqiong, et al.. Evaluation of varices bleeding and portal vein thrombosis by ARFI in patients with cirrhosis and esophagogastric varices [J]. Journal of Practical Hepatology, 2019, 22(6): 888-891.
[5]	Wang Yueyuan, Wang Yan, Zhang Dandan. Short-term efficacy of terlipressin and octreotide combination in treatment of cirrhotic patients complicated by hepatorenal syndrome [J]. Journal of Practical Hepatology, 2019, 22(5): 684-687.
[6]	Zhang Mei, Shi Xiuying, Li Linjuan, et al. Hepatic expression of interferon inducible protein -10 in patients with hepatitis B liver cirrhosis and hepatogenic diabetes mellitus [J]. Journal of Practical Hepatology, 2019, 22(5): 688-691.
[7]	Dan Zhuyongji, Liu Zhilan, Lu Yanyan, et al. Efficacy of endoscopic sequential variceal 1igation plus sclerotherapy in treatment of patients with hepatitis B-induced liver cirrhosis complicated by esophageal gastric varices bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 692-695.
[8]	Huang Hanjun, Lu Fengrong, Zhang Can. Clinical value of MRI scanning based on exchange hemodynamics model in evaluating liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 696-699.
[9]	Zhao Fangfang, Zhai Yongzhen, Feng Guohe. Efficacy and safety of autologous peripheral blood stem cell transplantation in patients with hepatitis B cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 700-703.
[10]	Chen Shan, Zhuang Huashuai, Xing Yixi, et al. Preventive application of meropenem in patients with liver cirrhosis complicated by upper gastrointestinal bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 704-707.
[11]	Xu Qilin, Hao Shaohuan, Ran Bo. Risk factors of portal vein thrombosis after splenectomy in patients with liver cirrhosis and portal hypertension [J]. Journal of Practical Hepatology, 2019, 22(5): 708-711.
[12]	Jin Lianghong, Li Xingjie, Guan Hongbo, et al. Clinical value of dual-energy CT iodine quantification combined with dynamic contrast-enhanced MRI in evaluating hepatic hemodynamics and liver functions in patients with hepatitis B liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 712-715.
[13]	Bian Xinqu, Chen Jie, Liu Yanmin, et al. Serum thyroid hormone level changes in patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy [J]. Journal of Practical Hepatology, 2019, 22(5): 716-719.
[14]	Xiao Han, Wang Li. Mechanisms of thrombocytopenia in liver cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 462-465.
[15]	Han Meiling, Chen Ping. Antiviral therapy in patients with liver cirrhosis and thrombocytopenia [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 466-469.

Early oral administration of Ensure in patients with liver cirrhosis complicated by esophageal -gastric varices after endoscopic hemostasis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments